Articles From: Nektar Therapeutics Reports Fourth Quarter and Year-End 2014 Financial Results to NeoStem Receives Drug Manufacture License for Irvine Facility


2015/2/24
SAN FRANCISCO , Feb.
Sign-up for Nektar Therapeutics Reports Fourth Quarter and Year-End 2014 Financial Results investment picks
2015/2/6
LINCOLN, Neb.
Sign-up for Nelnet to Announce Fourth Quarter and Year-End Results on Feb. 26; Dividend Approved investment picks
2015/1/9
By David Benoit and Jacob Bunge Nelson Peltz's investment firm launched a fight against DuPont Co.
Sign-up for Nelson Peltz demands 4 DuPont board seats investment picks
2014/12/1
BALTIMORE , Dec.
Sign-up for Nelson Peltz Resigns From Legg Mason Board of Directors investment picks
2014/12/10
PAR Springer-Miller Systems, Inc. (PSMS) — a wholly owned subsidiary of PAR Technology Corporation (NYSE:PAR) and the leading provider of custom guest-centric hospitality management systems, today announces that Nemacolin Woodlands Resort has selected the SMS |Host® Hospitality Management System & SMS |Touch™ Fine Dining for their 318-room luxury resort in Southwestern Pennsylvania.
Sign-up for Nemacolin Woodlands Resort Deploys PAR Springer-Miller’s Hospitality Management and Point of Sale Systems investment picks
2015/1/12
COSTA MESA, Calif., Jan.
Sign-up for NEMUS Bioscience Announces Appointment of Thomas A. George, CFO of Deckers Brands, to Its Board of Directors investment picks
2014/12/4
COSTA MESA, Calif., Dec.
Sign-up for NEMUS to Move Forward With Cannabinoid-Based Therapy for Open-Angle Glaucoma investment picks
2014/12/8
LANSING, Mich.
Sign-up for Neogen acquires assets of its Chinese distributor investment picks
2014/12/4
LANSING, Mich.
Sign-up for Neogen names COO investment picks
2014/12/18
LANSING, Mich.
Sign-up for Neogen reports 26% increase in net income investment picks
2015/2/5
LANSING, Mich.
Sign-up for Neogen responds to cumin and spice blend contamination involving peanut investment picks
2015/1/22
Company Now Projecting 36% Year-Over-Year Revenue Growth in Quarter 4 FT.
Sign-up for NeoGenomics Raises Revenue Guidance to $25 Million and EPS Guidance to $0.01 - $0.02 per share for Quarter 4, 2014 investment picks
2015/2/24
Company's Commitment to Fast-paced Innovation Continues to Drive Growth.
Sign-up for NeoGenomics Reports Record Revenue of $25.0 Million, Adjusted EBITDA of $2.8 MM and Net Income of $0.02 per Share for the Fourth Quarter 2014 investment picks
2015/2/4
FT. MYERS, Fla., Feb.
Sign-up for NeoGenomics Schedules its Q4 2014 and Full Year 2014 Earnings Release for February 24, 2015 investment picks
2015/1/7
STOCKHOLM, Sweden, Jan.
Sign-up for Neonode Awarded All-In-One PC Deal Including Prepayment With a Global Tier ONE PC OEM investment picks
2015/1/7
STOCKHOLM, Sweden, Jan.
Sign-up for Neonode Signs Technology Development Agreement With an Additional Global Tier One Printer OEM investment picks
2014/12/15
STOCKHOLM, Sweden, Dec.
Sign-up for Neonode to Demonstrate Cutting Edge Touch Technologies at CES 2015 investment picks
2015/2/20
STOCKHOLM, Sweden, Feb.
Sign-up for Neonode to Report Fourth Quarter and Year 2014 Results on March 12, 2015 investment picks
2014/12/19
STOCKHOLM, Sweden, Dec.
Sign-up for Neonode(R) to Present at Needham Annual Growth Conference on January 15, 2015 investment picks
2015/1/5
NeoPhotonics Corporation (NYSE:NPTN), today announced that it has completed the acquisition of the tunable laser product lines of EMCORE Corporation (NASDAQ: EMKR) for approximately $17.5 million.
Sign-up for NeoPhotonics Completes Acquisition of EMCORE’s Narrow Linewidth Tunable Laser Product Line investment picks
2015/1/15
NeoPhotonics Corporation (NYSE:NPTN), a leading designer and manufacturer of hybrid photonic integrated optoelectronic modules and subsystems for bandwidth-intensive, high speed communications networks, reported that in connection with the completion of its acquisition of the Narrow Linewidth Tunable Laser Product Line of EMCORE Corporation, the company granted special inducement equity awards under the NeoPhotonics 2011 Inducement Award Plan to retain certain former Emcore employees (23 in total) as employees of the NeoPhotonics group.
Sign-up for NeoPhotonics Reports Equity Award Inducement Grants to Employees Hired with the Acquisition of Emcore’s Narrow Linewidth Tunable Laser Product Line investment picks
2015/2/20
NeoPhotonics Corporation (NYSE:NPTN), a leading designer and manufacturer of hybrid photonic integrated optoelectronic modules and subsystems for bandwidth-intensive, high-speed communications networks, will report financial results for the fourth quarter and year ended December 31, 2014, after market close on Tuesday, March 3, 2015.
Sign-up for NeoPhotonics to Host Conference Call to Discuss 2014 Fourth Quarter and Year End Financial Results on Tuesday, March 3, 2015 investment picks
2015/1/8
NeoPhotonics Corporation (NYSE:NPTN), a leading designer and manufacturer of hybrid photonic integrated optoelectronic modules and subsystems for bandwidth-intensive, high-speed communications networks, today announced that management of NeoPhotonics will present at the 17 th Annual Needham Growth Conference in New York, NY on Wednesday, January 14, 2015 at 10:00 AM EST.
Sign-up for NeoPhotonics to Present at the 17th Annual Needham Growth Conference investment picks
2015/1/12
NEW YORK and SAN DIEGO, Jan.
Sign-up for NeoStem and Invetech Announce Agreement to Develop Closed Processing System for Cell Therapy Manufacturing investment picks
2014/12/1
NEW YORK, Dec.
Sign-up for NeoStem and PCT, A NeoStem Company, to Present at Multiple December Conferences investment picks
2015/1/20
NEW YORK, Jan.
Sign-up for NeoStem Receives Drug Manufacture License for Irvine Facility investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Nektar Therapeutics Reports Fourth Quarter and Year-End 2014 Financial Results to NeoStem Receives Drug Manufacture License for Irvine Facility
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent